Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.4425
-0.0020 (-0.45%)
Sep 11, 2025, 10:47 AM - Market open
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $63.73 million as of September 11, 2025. Its market cap has decreased by -90.09% in one year.
Market Cap
63.73M
Enterprise Value
36.19M
1-Year Change
-90.09%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has decreased from $160.29M to $63.73M, a decrease of -60.24%. That is a compound annual growth rate of -13.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 63.39M | -36.37% |
| Dec 31, 2024 | 99.62M | -61.49% |
| Dec 29, 2023 | 258.72M | 608.33% |
| Dec 30, 2022 | 36.52M | -84.43% |
| Dec 31, 2021 | 234.63M | -52.60% |
| Dec 31, 2020 | 494.96M | -2.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |